Quantum Molecular Resonance Electrotherapy in Severe Dry Eye Disease - Trial NCT06119386
Access comprehensive clinical trial information for NCT06119386 through Pure Global AI's free database. This phase not specified trial is sponsored by Centro Oculistico Borroni and is currently Completed. The study focuses on Dry Eye. Target enrollment is 81 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centro Oculistico Borroni
Timeline & Enrollment
N/A
Nov 03, 2022
Feb 25, 2023
Primary Outcome
Ocular surface evaluation
Summary
To evaluate the efficacy and safety of Quantum Molecular Resonance (QMR) treatment in
 patients with severe dry eye disease (DED), as well as its effects on aqueous-deficient
 (ADDE), evaporative (EDE) and mixed (MDE) dry eye.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06119386
Device Trial